Cubist Names New CFO

Cubist Pharmaceuticals (NASDAQ: CBST  ) has appointed a new chief financial officer. The new top finance executive at the company is Michael Tomsicek, who replaces the outgoing David McGirr.

Tomsicek has been senior vice president and deputy CFO since July of last year. He joined the company in 2010 as vice president of corporate finance. Before that, he worked for eight years at General Electric Healthcare, serving as finance manager of global operations, CFO of the diagnostic ultrasound segment, and CFO of the global ultrasound product group.

Tomsicek's predecessor, McGirr, will become senior advisor to the chief executive officer and retire next year.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2292449, ~/Articles/ArticleHandler.aspx, 12/18/2014 9:34:08 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement